ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 191 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $68,159 | -48.6% | 13,714 | -49.0% | 0.11% | -33.7% |
| Q1 2023 | $132,723 | -32.7% | 26,867 | -14.3% | 0.16% | -28.5% |
| Q4 2022 | $197,122 | -21.2% | 31,339 | +35.4% | 0.23% | -20.3% |
| Q3 2022 | $250,000 | -41.9% | 23,137 | -38.6% | 0.29% | -3.4% |
| Q2 2022 | $430,000 | +205.0% | 37,713 | +144.1% | 0.30% | +179.2% |
| Q1 2022 | $141,000 | -7.8% | 15,449 | +51.1% | 0.11% | -35.0% |
| Q4 2021 | $153,000 | – | 10,223 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |